TAIPEI, Taiwan--(BUSINESS WIRE)-- Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the pharmaceutical industry, is celebrating 40 successful years of practice in its Taipei, Taiwan, location on November 11, 2011.
The facility has made many significant changes and improvements throughout the last four decades, including an enhanced lab environment and extended operational capabilities.
“Over the past 40 years, we have worked on more than a half-million testing substances in a wide battery of pharmacology assays,” stated Fong-Chi Cheng, Ricerca Taiwan senior director and site manager. “Because of our continuous improvements, the facility now performs studies for over 500 clients each year.”
In June 2011, the Taiwan facility was awarded the Taipei Labor Bureau’s Titiana Award, or Happiness Enterprise Award, for providing a safe work environment, friendly workplace, excellent training development and good compensation and benefits to workers. Currently, the company is working to acquire its certificate from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) in 2013.
“Ricerca is very proud of our Taiwan facility. It has provided top-quality service for 40 years, and we are looking forward to the future and what it holds,” said Ian Lennox, CEO of Ricerca.
Ricerca Biosciences provides a full range of preclinical services from early discovery medicinal chemistry, compound screening, profiling and lead optimization through full drug safety, metabolism and efficacy development support, as well as clinical supply and commercial API production capability.
About Ricerca Biosciences
Ricerca Biosciences, offers a comprehensive suite of discovery, preclinical and development services to support drug candidates from discovery through IND and NDA on a global scale. Capabilities include molecular through in vivo screening and profiling, medicinal chemistry, IND-enabling toxicology, API process chemistry and cGMP manufacturing of clinical and commercial API. At Ricerca, our scientific excellence and reliable, cost-effective strategies help accelerate your drug discovery programs via our U.S.-based facilities in Concord, Ohio, and Bothell, Washington, and our ISO 9001-certified facilities in Taipei, Taiwan, and Lyon, France. The Lyon facility also holds AAALAC certification.
Kelly Sladek, 308-237-5567
KEYWORDS: United States Asia Pacific North America Ohio Taiwan
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Research Science